Brief: Egetis Therapeutics CFO Acquired SEK 899,125 Worth Of Co Share
Dec 1 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST: CFO OF EGETIS THERAPEUTICS YILMAZ MAHSHID ACQUIRED SEK 899,125 WORTH OF CO SHARE ON NOV 26-FINANSINSPEKTIONEN Source text: [ID:] Further company coverage: EGTX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1